This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mmv Medicines for Malaria Venture, Rutgers, The State University of New Jersey, St. Jude Children's Research Hospital. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016
Title: The Innovative Contributions of Wendyam Armand Guiguemde
Introduction
Wendyam Armand Guiguemde is a notable inventor based in Memphis, TN, who has made significant contributions to the field of antimalarial therapies. His work focuses on developing novel compounds that can aid in the treatment and prevention of malaria, a disease that continues to affect millions worldwide.
Latest Patents
Guiguemde holds a patent for "Substituted 2-alkyl-1-OXO-N-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies." This invention relates to novel substituted compounds, synthetic methods for their production, pharmaceutical compositions containing these compounds, and methods for treating and preventing malaria. The patent serves as a valuable resource for researchers and healthcare professionals in the fight against this disease.
Career Highlights
Throughout his career, Guiguemde has worked with esteemed organizations such as St. Jude Children's Research Hospital and Medicines for Malaria Venture. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Rodney Kiplin Guy and Fangyi Zhu. Their collaborative efforts have further advanced the research and development of effective antimalarial treatments.
Conclusion
Wendyam Armand Guiguemde's innovative work in the field of antimalarial therapies highlights the importance of research and development in combating infectious diseases. His contributions through patents and collaborations continue to pave the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile